3 High-Flying TSX Stocks That Show No Signs of Slowing Down

Three high-flying TSX stocks are strong buys for investors looking for outsized gains in 2024 and beyond.

| More on:

Canada’s benchmark stock exchange has been resilient despite the bumpy road for most of 2024. Only the communications sector (-4.1%), out of 11 primary sectors, is in the red at the start of September. Moreover, some individual stocks continue to beat the TSX and buck elevated market volatility.

If you’re looking for high flyers, CES Energy Solutions (TSX:CEU), Héroux-Devtek (TSX:HRX), and KITS Eyecare (TSX:KITS) are logical choices.  All three growth stocks show no signs of slowing down and are well-positioned to become big winners this year

Energy

CES Energy, a small-cap stock, outperforms its larger peers in the energy sector. At only $7.62 per share, current investors delight in the 123.2% year-to-date gain on top of the modest 1.6% dividend offer. The $1.8 billion company provides technically advanced consumable chemical solutions to North America’s oil and gas industry.

The record-setting results in Q2 2024 indicate the financial resiliency of CES’ capex-light and asset-light consumable chemicals business model. In the three months ending June 30, 2024, revenue increased 4% to a record $553.2 million versus Q2 2023, while net income jumped 42% year-over-year to $48.1 million.

According to management, the underlying business model generates significant surplus free cash flow (FCF). Strong energy industry fundamentals remain the tailwind for the stock because it supports critical drilling and production activities for oil and natural gas.

Industrial

Héroux-Devtek is a close second to CES Energy in terms of market-beating returns. At $31.35 per share, the industrial stock is up 106.3% year-to-date. Had you invested $15,200 (1,000 shares) at year-end 2023, your money would be almost double or $31,350 today.

The $1.1 billion caters to the aerospace industry, specializing in landing gear, actuation systems, components, and allied services. Despite the inflationary environment, sales have been robust. In Q1 2024, revenue rose 23.7% to $174 million compared to Q1 2023.

In the same quarter, operating and net incomes climbed 159.1% and 216% year-over-year, respectively, to $19.4 million and $12.6 million. Notably, FCF reached $1.2 million from -$20.5 million a year ago. Besides the good quarterly performance, Martin Brassard, President and CEO of Héroux-Devtek, notes the growing civil and defence markets.

Specialty retail

KITS Eyecare flies under the radar but is soaring thus far in 2024. At $11.30 per share (+81.1% year-to-date), the retail stock is up 120.7% from a year ago. The $356.5 million Vancouver-based company is a known vertically integrated eyecare provider. It offers a wide selection of premium eyecare products, such as eyeglasses, sunglasses, progressives, and contact lenses.

The stock’s performance reflects a thriving business. In Q2 2024, revenue increased 26% to a record $37.9 million compared to Q2 2024. KITS reported a $0.2 million net income versus the $1.2 million net loss from a year ago. The glasses business grew more than 41% in the quarter.

Because of strong demand in the last two months and record-breaking sales for the week ending August 31, 2024, KITS expects Q3 revenue to exceed its 32% year-over-year growth rate target.

Big winners

CES Energy Solutions, Héroux-Devtek, and KITS Eyecare have delivered superior returns amid a challenging landscape. There should be no obstacles to outsized gains in 2024 and beyond.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Kits Eyecare. The Motley Fool has a disclosure policy.

More on Dividend Stocks

monthly desk calendar
Dividend Stocks

Monthly Dividend Leaders: 3 TSX Stocks Paying Dividends Every 30 Days

These monthly dividend stocks offer a high yield of over 7% and have durable payouts.

Read more »

space ship model takes off
Dividend Stocks

2 Stocks I’d Avoid in 2025 (and 1 I’d Buy)

Two low-priced stocks are best avoided for now but a surging oil bellwether is a must-buy.

Read more »

Paper Canadian currency of various denominations
Dividend Stocks

Want 6% Yield? 3 TSX Stocks to Buy Today

These TSX dividend stocks have sustainable payouts and are offering high yields of 6% near their current price levels.

Read more »

A woman shops in a grocery store while pushing a stroller with a child
Dividend Stocks

Is Metro Stock a Buy for its 1.5% Dividend Yield?

Metro is a defensive stock that's a reasonable buy here for a long-term investment.

Read more »

Man data analyze
Dividend Stocks

This 7.2% Dividend Stock Pays Cash Every Single Month

This top dividend stock is offering massive dividends, but are they safe? Let's dig in today.

Read more »

ETF stands for Exchange Traded Fund
Dividend Stocks

The Smartest Dividend ETF to Buy With $500 Right Now

The Vanguard Canadian High Yield ETF (TSX:VDY) is one of the best Canadian dividend ETFs.

Read more »

analyze data
Dividend Stocks

Here’s Why the Average TFSA for Canadians Aged 41 Isn’t Enough

The average TFSA simply isn't enough for most Canadians in their early 40s. Here's how to catch up.

Read more »

cloud computing
Dividend Stocks

Insurance Showdown: Better Buy, Great-West Life or Manulife Stock?

GWO stock and MFC stock are two of the top names in insurance, but which holds the better outlook?

Read more »